Delivery Order SPE2DB20D3103-SPE2DB25FP6A3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,163.12 to AmerisourceBergen Drug Corp for the supply of Prilosec DR 10 mg Suspension in 30-count packaging. This firm fixed-price contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under the company's larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,475.62 Delivery Order (SPE2DB23FRVD2) is for the supply of 30 suspension packages of the drug Prilosec 10 mg. The contract has a firm fixed price and an ultimate completion date of August 17, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation and a leading global pharmaceutical sourcing and distribution services company. The $4,802.34 award is for the delivery of Prilosec DR 10 mg suspension medication to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,722.17 firm fixed-price contract is for the supply of Prilosec DR 10 mg suspension medication, with a completion date of December 24, 2024. This contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of Prilosec DR 10 mg suspension in 30-count packages to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract, valued at $1,599.48, was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, on May 22, 2024, with a completion date of May 23, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
- This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The $1,348.70 firm fixed price contract is for the provision of Prilosec DR 10 mg pharmaceutical suspension. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and is providing these pharmaceutical products from its corporate office in Conshohocken, Pennsylvania. This contract does not have a set-aside...
- This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order (SPE2DB20D3101|SPE2DB24FRBE2) from the Defense Logistics Agency (DLA) for the supply of Prilosec DR 2.5 mg Suspension, valued at $12,325.17. The contract has a ceiling value of $12,325.17 and an ultimate completion date of February 9, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role...
- The Defense Logistics Agency awarded a $1,533.60 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of 500 capsules of Omeprazole DR 40 mg. This is a non-set-aside contract with an ultimate completion date of July 28, 2025, and represents a delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The work will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,256.67 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Omeprazole DR 20 mg capsules (1,000 units). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 6, 2025, to be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this...
- The Defense Logistics Agency awarded a $711 delivery order to Amerisourcebergen Drug Corporation for omeprazole capsules. Under this firm fixed price contract, Amerisourcebergen will provide 100 count bottles of the 10mg proton pump inhibitor to locations in Conshohocken, Pennsylvania between July 14 and July 17, 2023. As a major supplier of pharmaceuticals and medical supplies, Amerisourcebergen frequently receives delivery orders under DLA's Prime Vendor program to support the health needs...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP6A3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,156.92 to AmerisourceBergen Drug Corp for the supply of Prilosec DR 10 mg suspension (30-count). This firm fixed-price delivery order, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-set-aside award executed through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company holds a robust portfolio of federal contract awards predominantly with the Defense Logistics Agency, demonstrating capability to meet federal procurement requirements across a comprehensive range of therapeutic domains. This specific delivery order for Prilosec, a proton pump inhibitor medication used to treat gastroesophageal reflux disease and related conditions, exemplifies the type of brand-name pharmaceutical products the company routinely supplies through its master contract vehicle to support Defense Health Agency operations and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 7/22/25 |